{"id":"NCT05108922","sponsor":"Eli Lilly and Company","briefTitle":"A Study of Donanemab (LY3002813) Compared With Aducanumab in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 4)","officialTitle":"A Phase 3, Open-Label, Parallel-Group, 2-Arm Study to Investigate Amyloid Plaque Clearance With Donanemab Compared With Aducanumab-avwa in Participants With Early Symptomatic Alzheimer's Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2021-11-16","primaryCompletion":"2022-09-09","completion":"2023-09-19","firstPosted":"2021-11-05","resultsPosted":"2023-11-02","lastUpdate":"2024-11-29"},"enrollment":148,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Mild Cognitive Impairment (MCI)","Alzheimer Disease"],"interventions":[{"type":"DRUG","name":"Donanemab","otherNames":["LY3002813"]},{"type":"DRUG","name":"Aducanumab","otherNames":[]}],"arms":[{"label":"Donanemab","type":"EXPERIMENTAL"},{"label":"Aducanumab","type":"ACTIVE_COMPARATOR"}],"summary":"The main purpose of this study is to compare donanemab to aducanumab on brain amyloid plaque clearance in participants with early symptomatic Alzheimer's Disease (AD).","primaryOutcome":{"measure":"Percentage of Participants Who Reach Complete Amyloid Plaque Clearance on Florbetapir F18 Positron Emission Tomography (PET) Scan (Superiority) on Donanemab Versus Aducanumab","timeFrame":"6 Months","effectByArm":[{"arm":"Aducanumab","deltaMin":1.6,"sd":null},{"arm":"Donanemab","deltaMin":37.9,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"50 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":8,"exclusionCount":7},"locations":{"siteCount":31,"countries":["United States"]},"refs":{"pmids":["40390253"],"seeAlso":["https://trials.lillytrialguide.com/en-US/trial/7lW96VnHH5irho2IpKQCFM"]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":69},"commonTop":["Amyloid related imaging abnormality-oedema/effusion","Covid-19","Amyloid related imaging abnormality-microhaemorrhages and haemosiderin deposits","Headache","Fall"]}}